CLUSTER Sustainability
The CLUSTER Consortium is a 5-year Medical Research Council project, funded until summer 2023. We want to make long term impacts on the treatment of JIA and JIA-uveitis. On this page, you can learn about how we plan to do this through Our Mission, Our Vision and how we plan to do this.
CLUSTER's Mission
Mission : To improve health outcomes in JIA by advancing the care of patients with arthritis and uveitis through understanding of disease mechanisms and outcomes.
“Cluster works as a team. Clinicans and scientists from diverse fields with patients and families build the research together with immense vision and energy and hope for the future”
CLUSTER's Vision
Vision : Develop new understanding and classification of disease, by development of tools that help to predict disease course and likely response to medicines, ultimately leading to development of new and personalised therapies for JIA (arthritis and uveitis). This will be achieved by multidisciplinary working with experts, applying the best methods for research, such as artificial intelligence, to make the most of the biomedical data revolution. This will all be done with patients at the heart of research, ensuring that our research is open and explainable to all.
How will we achieve this?
We do this by:
Working with exceptional researchers and clinicians
Being collaborative and multidisciplinary
Making data findable, accessible, interoperable and reusable to speed up and maximise research impact globally
Developing careers
Working as a community of patients/Carers/Industry/Charities/NHS and academia
CLUSTER is one of the MRC funded consortia
looking into stratified medicine of juvenile idiopathic arthritis.
For more information, see the MRC website using the following link:
Consortia
https://www.ukri.org/what-we-offer/browse-our-areas-of-investment-and-support/precision-medicine/